Financials

  • Market Capitalization 463.2841 M
  • Employee 45
  • Founded 1995
  • CEO Diem Nguyen
  • Website www.siga.com
  • Headquarter Delaware, United States
  • FIGI BBG000BKXWV1
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
7.33
Price to sales ratio
3.12
Dividends per share
0.6
Dividend yield %
9.98

SIGA Technologies Inc

SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, based in New York City, which develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications.

Notícias